Candel Therapeutics
CADL
CADL
71 hedge funds and large institutions have $156M invested in Candel Therapeutics in 2024 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 33 increasing their positions, 9 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
37% more funds holding
Funds holding: 52 → 71 (+19)
21.4% more ownership
Funds ownership: 20.86% → 42.26% (+21%)
Holders
71
Holding in Top 10
2
Calls
$9.79M
Puts
$4.83M
Top Buyers
| 1 | +$34M | |
| 2 | +$25.9M | |
| 3 | +$13.9M | |
| 4 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$6.54M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.41M |
Top Sellers
| 1 | -$156K | |
| 2 | -$141K | |
| 3 | -$103K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$29.5K |
| 5 |
Vontobel Holding
Zurich,
Switzerland
|
-$26K |